NASDAQ:NICE - NICE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $288.83
  • Forecasted Upside: 25.83 %
  • Number of Analysts: 12
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$229.54
▲ +1.1 (0.48%)
1 month | 3 months | 12 months
Get New NICE Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NICE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NICE

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$288.83
▲ +25.83% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for NICE in the last 3 months. The average price target is $288.83, with a high forecast of $338.00 and a low forecast of $254.00. The average price target represents a 25.83% upside from the last price of $229.54.
Buy
The current consensus among 12 investment analysts is to buy stock in NICE. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/29/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/28/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/25/2021WedbushBoost Price TargetOutperform$275.00 ➝ $285.00Medium
i
2/25/2021Morgan StanleyBoost Price TargetOverweight$334.00 ➝ $338.00Medium
i
2/19/2021WedbushBoost Price TargetOutperform$275.00 ➝ $285.00High
i
2/19/2021Pritchard CapitalBoost Price TargetBuy$292.00 ➝ $312.00High
i
2/19/2021Royal Bank of CanadaBoost Price TargetSector Perform$250.00 ➝ $266.00High
i
2/11/2021OppenheimerReiterated RatingOutperform$290.00Low
i
1/29/2021BarclaysUpgradeEqual Weight ➝ Overweight$246.00 ➝ $330.00Low
i
12/17/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$230.00 ➝ $334.00Medium
i
12/9/2020DA DavidsonUpgradeNeutral ➝ Buy$250.00 ➝ $275.00Low
i
11/13/2020Royal Bank of CanadaBoost Price TargetSector Perform$216.00 ➝ $250.00High
i
11/13/2020WedbushBoost Price TargetOutperform$250.00 ➝ $275.00High
i
11/13/2020Rosenblatt SecuritiesBoost Price TargetBuy$265.00 ➝ $290.00High
i
11/13/2020Morgan StanleyBoost Price TargetEqual Weight$212.00 ➝ $230.00High
i
11/12/2020Jefferies Financial GroupBoost Price TargetBuy$265.00 ➝ $285.00High
i
11/12/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$210.00 ➝ $261.00Low
i
Rating by Paul Coster at JPMorgan Chase & Co.
11/3/2020Bank of AmericaInitiated CoverageBuy$280.00Medium
i
10/22/2020Rosenblatt SecuritiesBoost Price TargetBuy$260.00 ➝ $265.00Low
i
Rating by Ryan Koontz at Rosenblatt Securities
9/16/2020CitigroupLower Price Target$262.00 ➝ $254.00Low
i
9/16/2020OppenheimerBoost Price TargetAverage ➝ Outperform$230.00 ➝ $250.00Low
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
8/11/2020OppenheimerReiterated RatingBuy$230.00Low
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
8/7/2020Morgan StanleyBoost Price TargetEqual Weight$156.00 ➝ $212.00High
i
8/6/2020Jefferies Financial GroupBoost Price TargetBuy$195.00 ➝ $265.00High
i
7/9/2020CitigroupUpgradeNeutral ➝ Buy$221.00Low
i
6/26/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$172.00Low
i
6/24/2020WedbushBoost Price Target$200.00 ➝ $230.00Low
i
6/18/2020OppenheimerBoost Price TargetPositive ➝ Outperform$180.00 ➝ $200.00Medium
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
5/17/2020Royal Bank of CanadaReiterated RatingHoldLow
i
5/14/2020Rosenblatt SecuritiesReiterated RatingBuy$195.00Medium
i
Rating by Ryan Koontz at Rosenblatt Securities
5/14/2020OppenheimerReiterated RatingBuy$180.00Medium
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
5/14/2020Jefferies Financial GroupBoost Price TargetBuy$180.00 ➝ $195.00Medium
i
5/11/2020Morgan StanleyBoost Price TargetEqual Weight$133.00 ➝ $144.00Low
i
3/25/2020Morgan StanleyLower Price TargetEqual Weight$173.00 ➝ $133.00Low
i
2/21/2020Jefferies Financial GroupBoost Price TargetBuy$179.00 ➝ $209.00Medium
i
2/14/2020Royal Bank of CanadaBoost Price TargetMarket Perform$182.00Low
i
2/14/2020Morgan StanleyBoost Price TargetEqual Weight$160.00 ➝ $173.00Medium
i
2/14/2020DA DavidsonReiterated RatingPositive ➝ Neutral$175.00Medium
i
2/14/2020CitigroupBoost Price TargetNeutral$156.00 ➝ $193.00Medium
i
2/14/2020Rosenblatt SecuritiesBoost Price TargetBuy$187.00 ➝ $195.00Medium
i
Rating by Ryan Koontz at Rosenblatt Securities
2/14/2020WedbushBoost Price TargetOutperform$185.00 ➝ $200.00Medium
i
2/13/2020OppenheimerReiterated RatingBuy$193.00Medium
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
1/27/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$163.00Low
i
11/27/2019OppenheimerBoost Price TargetOutperform$166.00 ➝ $170.00Low
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
11/15/2019WedbushBoost Price TargetOutperform$165.00 ➝ $170.00Low
i
11/15/2019Rosenblatt SecuritiesReiterated RatingBuy$187.00Low
i
Rating by Ryan Koontz at Rosenblatt Securities
10/15/2019OppenheimerSet Price TargetBuy$166.00Low
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
9/4/2019Rosenblatt SecuritiesInitiated CoverageBuy$187.00Low
i
8/9/2019Morgan StanleySet Price TargetHold$140.00Low
i
Rating by Meta Marshall at Morgan Stanley
8/9/2019JMP SecuritiesBoost Price TargetMarket Outperform$164.00 ➝ $185.00Low
i
8/9/2019Jefferies Financial GroupBoost Price TargetBuy$166.00 ➝ $179.00Low
i
7/29/2019JPMorgan Chase & Co.Boost Price TargetOverweight$150.00 ➝ $166.00Low
i
5/17/2019CitigroupBoost Price TargetNeutral$117.00 ➝ $137.00Medium
i
5/17/2019DA DavidsonBoost Price TargetPositive ➝ Neutral$140.00Low
i
5/17/2019Morgan StanleyBoost Price TargetEqual Weight$117.00 ➝ $128.00Low
i
5/17/2019JMP SecuritiesBoost Price TargetMarket Outperform$140.00 ➝ $164.00Low
i
5/16/2019Jefferies Financial GroupBoost Price TargetBuy$166.00Low
i
5/16/2019WedbushReiterated RatingBuy$160.00Low
i
4/24/2019BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$124.00 ➝ $150.00Low
i
4/22/2019JMP SecuritiesReiterated RatingOutperform$120.00 ➝ $140.00High
i
4/22/2019WedbushReiterated RatingOutperform ➝ Positive$145.00 ➝ $155.00High
i
4/18/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$125.00 ➝ $150.00Medium
i
4/17/2019DA DavidsonBoost Price TargetNeutral ➝ Neutral$110.00 ➝ $125.00High
i
4/17/2019OppenheimerBoost Price TargetOutperform ➝ Outperform$125.00 ➝ $145.00High
i
4/17/2019Jefferies Financial GroupBoost Price TargetBuy$134.00 ➝ $149.00High
i
2/15/2019WedbushBoost Price Target$145.00N/A
i
1/7/2019Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$107.00 ➝ $117.00Low
i
11/9/2018Royal Bank of CanadaBoost Price TargetMarket Perform$120.00Medium
i
10/18/2018WedbushInitiated CoverageOutperform ➝ Outperform$130.00Medium
i
9/20/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$132.00Low
i
8/10/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$104.00 ➝ $110.00Medium
i
8/10/2018BarclaysReiterated RatingNeutral ➝ Hold$114.00Medium
i
Rating by Tavy Rosner at Barclays PLC
6/22/2018DA DavidsonInitiated CoverageNeutral$110.00Low
i
5/16/2018Jefferies Financial GroupReiterated RatingBuy$119.00Low
i
5/10/2018BarclaysSet Price TargetHold$100.00Low
i
Rating by Tavy Rosner at Barclays PLC
5/8/2018Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$101.00Low
i
Rating by Sanjit Singh at Morgan Stanley
2/21/2018Chardan CapitalReiterated RatingNeutral ➝ Neutral$91.00 ➝ $99.00Low
i
2/18/2018BarclaysReiterated RatingHold$93.00High
i
1/18/2018Jefferies Financial GroupUpgradeHold ➝ Buy$87.00Medium
i
12/13/2017OppenheimerReiterated RatingBuy$90.00 ➝ $100.00Low
i
12/13/2017CitigroupReiterated RatingOutperform$90.00 ➝ $100.00Medium
i
11/6/2017Chardan CapitalDowngradeBuy ➝ Neutral$91.00N/A
i
11/3/2017CitigroupBoost Price TargetNeutral$83.00 ➝ $93.00N/A
i
11/3/2017Jefferies Financial GroupBoost Price TargetHold$84.00 ➝ $87.00N/A
i
11/3/2017JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralN/A
i
10/16/2017Chardan CapitalBoost Price TargetBuy ➝ Buy$84.00 ➝ $91.00N/A
i
10/6/2017Jefferies Financial GroupInitiated CoverageHold ➝ Hold$84.00N/A
i
8/21/2017Royal Bank of CanadaReiterated RatingHold$80.00Low
i
8/7/2017Chardan CapitalBoost Price TargetBuy ➝ Buy$76.00 ➝ $84.00Low
i
8/7/2017BarclaysReiterated RatingHoldLow
i
Rating by Tavy Rosner at Barclays PLC
8/4/2017BarclaysSet Price TargetHold$75.00 ➝ $80.00Low
i
Rating by Tavy Rosner at Barclays PLC
8/4/2017OppenheimerBoost Price TargetOutperform$80.00 ➝ $85.00Low
i
6/7/2017CitigroupInitiated CoverageNeutral ➝ Neutral$82.00Low
i
5/12/2017OppenheimerReiterated RatingOutperform$80.00Low
i
2/21/2017Chardan CapitalReiterated RatingBuyN/A
i
Rating by Lena Rogovin at Chardan Capital
2/18/2017BarclaysSet Price TargetHold$75.00N/A
i
Rating by Tavy Rosner at Barclays PLC
2/14/2017Chardan CapitalReiterated RatingBuy$76.00N/A
i
Rating by Lena Rogovin at Chardan Capital
2/10/2017The Goldman Sachs GroupInitiated CoverageNeutral$76.00N/A
i
1/13/2017Imperial CapitalDowngradeOutperform ➝ In-Line$74.00 ➝ $76.00N/A
i
Rating by J. Kessler at Imperial Capital
1/11/2017Chardan CapitalBoost Price TargetBuy$72.00 ➝ $76.00N/A
i
Rating by Lena Rogovin at Chardan Capital
12/21/2016OppenheimerReiterated RatingOutperform$75.00N/A
i
11/14/2016Chardan CapitalReiterated RatingBuy$72.00N/A
i
Rating by Lena Rogovin at Chardan Capital
11/11/2016JMP SecuritiesReiterated RatingBuyN/A
i
Rating by greg mcdowell at JMP Securities
10/5/2016Imperial CapitalReiterated RatingOutperform$74.00N/A
i
9/26/2016OppenheimerReiterated RatingOutperform$75.00N/A
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
8/31/2016JMP SecuritiesReiterated RatingBuyN/A
i
Rating by greg mcdowell at JMP Securities
7/28/2016Chardan CapitalBoost Price TargetBuy$70.00 ➝ $72.00N/A
i
7/17/2016Imperial CapitalReiterated RatingOutperform$74.00N/A
i
6/30/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Paul Coster at JPMorgan Chase & Co.
6/29/2016JPMorgan Chase & Co.Initiated CoverageOverweight$74.00N/A
i
6/23/2016OppenheimerReiterated RatingBuy$75.00N/A
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
6/22/2016Chardan CapitalInitiated CoverageBuy$63.00N/A
i
5/27/2016UBS GroupDowngradeBuy ➝ Neutral$77.00 ➝ $70.00N/A
i
5/26/2016OppenheimerReiterated RatingBuy$75.00N/A
i
Rating by Shaul Eyal at Oppenheimer Holdings Inc.
5/26/2016JPMorgan Chase & Co.UpgradeMarket Perform ➝ Outperform$78.00N/A
i
5/26/2016JMP SecuritiesUpgradeMarket Perform ➝ Outperform$78.00N/A
i
5/18/2016OppenheimerReiterated RatingBuy$75.00N/A
i
(Data available from 2/28/2016 forward)
NICE logo
NICE Ltd. provides enterprise software solutions worldwide. The company operates in two segments, Customer Engagement, and Financial Crime and Compliance. It offers CXone, a cloud native open platform that supports contact centers ranging from small single sites to distributed remote agents and enterprises; and a digital-first omnichannel customer engagement platform that supports various digital and self-service channels, which allows organizations to add and integrate new and emerging channels. The company also provides AI driven smarter processes and adaptive workforce engagement solutions. In addition, it offers NICE platform, a financial crime and compliance solution that handles various process, including detection, investigation, remediation, and reporting; and X-Sight, a cloud-based financial crime risk management platform-as-a-service. Further, the company provides professional service and support at various stages of the technology lifecycle, including defining requirements, planning, design, implementation, customization, optimization, maintenance, and ongoing support. It serves customers across various verticals, including banking, financial, telecommunications, healthcare, insurance, retail, travel, gaming, public safety, and state and local government. The company sells its solutions and products directly to customers, as well as indirectly through selected partners. NICE Ltd. has a strategic partnership with Information Services Group, Inc. to expand the automation ecosystem. The company was formerly known as NICE-Systems Ltd. and changed its name to NICE Ltd. in June 2016. NICE Ltd. was founded in 1986 and is based in Ra'anana, Israel.
Read More

Today's Range

Now: $229.54
$224.56
$231.93

50 Day Range

MA: $266.90
$228.44
$279.38

52 Week Range

Now: $229.54
$110.59
$288.73

Volume

463,123 shs

Average Volume

416,412 shs

Market Capitalization

$14.32 billion

P/E Ratio

74.05

Dividend Yield

N/A

Beta

0.76

Frequently Asked Questions

What sell-side analysts currently cover shares of NICE?

The following equities research analysts have issued stock ratings on NICE in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., DA Davidson, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Pritchard Capital, Rosenblatt Securities, Royal Bank of Canada, Wedbush, and Zacks Investment Research.
View the latest analyst ratings for NICE.

What is the current price target for NICE?

12 Wall Street analysts have set twelve-month price targets for NICE in the last year. Their average twelve-month price target is $288.83, suggesting a possible upside of 25.8%. Morgan Stanley has the highest price target set, predicting NICE will reach $338.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $254.00 for NICE in the next year.
View the latest price targets for NICE.

What is the current consensus analyst rating for NICE?

NICE currently has 2 hold ratings and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NICE will outperform the market and that investors should add to their positions of NICE.
View the latest ratings for NICE.

What other companies compete with NICE?

How do I contact NICE's investor relations team?

NICE's physical mailing address is 13 Zarchin Street P.O. Box 690, RA`ANANA L3, 4310602. The technology company's listed phone number is 972-9775-3151 and its investor relations email address is [email protected] The official website for NICE is www.nice.com.